One ex vivo study, performed by Durak et al., assessed the ability of UD to halt prostate cancer progression in prostate cancer tissue extracted from patients; the authors noted a significant inhibition of the adenosine deaminase (ADA) enzyme, involved in the elimination of the toxic deoxyinosine molecule. The gene discussed is ADA; the disease is prostate cancer.